Kenneth O Klepper insider trades: Diplomat Pharmacy (DPLO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 2, 2019 | DPLO | ↓ Sell | 859 | $4.84 | $4K | Direct | Oct 4, 2019 (2d) |
| Jun 4, 2019 | DPLO | ↓ Sell | 1,274 | $4.85 | $6K | Direct | Jun 5, 2019 (1d) |
| Jun 5, 2018 | DPLO | ↓ Sell | 1,680 | $24.27 | $41K | Direct | Jun 5, 2018 (0d) |
| Jan 13, 2011 | MHS | ↓ Sell | 148,938 | $65.00 | $9.7M | Direct | Jan 18, 2011 (5d) |
| Oct 23, 2009 | MHS | ↓ Sell10b5-1 | 119,400 | $58.00 | $6.9M | Direct | Oct 27, 2009 (4d) |
| Aug 20, 2009 | MHS | ↓ Sell10b5-1 | 73,334 | $55.00 | $4.0M | Direct | Aug 21, 2009 (1d) |
| Aug 6, 2007 | MHS | ↓ Sell | 5,500 | $83.19 | $458K | Direct | Aug 7, 2007 (1d) |
| Apr 23, 2007 | MHS | ↓ Sell | 56,900 | $74.48 | $4.2M | Direct | Apr 24, 2007 (1d) |
| Apr 23, 2007 | MHS | ↓ Sell | 29,850 | $74.27 | $2.2M | Direct | Apr 24, 2007 (1d) |
| Mar 12, 2007 | MHS | ↓ Sell | 9,300 | $70.00 | $651K | Direct | Mar 13, 2007 (1d) |
| Feb 28, 2007 | MHS | ↓ Sell10b5-1 | 4,300 | $68.00 | $292K | Direct | Mar 1, 2007 (1d) |
| Feb 21, 2007 | MHS | ↓ Sell | 22,950 | $66.81 | $1.5M | Direct | Feb 23, 2007 (2d) |
| Aug 10, 2006 | MHS | ↓ Sell10b5-1 | 14,500 | $64.00 | $928K | Direct | Aug 11, 2006 (1d) |
| Aug 8, 2006 | MHS | ↓ Sell10b5-1 | 14,500 | $62.00 | $899K | Direct | Aug 9, 2006 (1d) |
| Jul 24, 2006 | MHS | ↓ Sell10b5-1 | 14,500 | $60.00 | $870K | Direct | Jul 25, 2006 (1d) |
| Dec 16, 2005 | MHS | ↓ Sell | 52,544 | $57.00 | $3.0M | Direct | Dec 20, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kenneth O Klepper's insider trades
Kenneth O Klepper is a director at Diplomat Pharmacy (DPLO). Since Dec 16, 2005, Kenneth has reported no open-market purchases and 16 sales worth $35.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (39% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (15 filings), option exercises (10 filings), shares withheld for taxes (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DPLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.